Healthcare practice expanded to 3 locations via SBA 7(a) after declining higher-cost alternatives

Background

The practice is a single-owner outpatient physical therapy clinic that opened in 2018 in a suburban Atlanta market. Trailing-twelve-month revenue at the time of the expansion decision was $1.8M, with a 22% pre-tax net margin and a payor mix of roughly 58% commercial, 26% Medicare, 11% workers' comp, and 5% self-pay. The owner-physician holds 100% and works clinically about 22 hours per week alongside three full-time PTs and a part-time PTA.

Pre-deal balance sheet was unusually clean for a healthcare practice of this size — no business debt, no equipment leases, no SBA history. The original clinic buildout was funded from the owner's personal capital plus a five-year equipment lease that retired in 2023. Personal credit was 758. The practice carried $310K of cash on the balance sheet against $94K average monthly operating expenses — roughly 3.3 months of runway.

The expansion thesis: acquire a struggling single-location PT clinic 14 miles north for $640K (turnaround play with strong location and payor contracts but weak operations) and build out a ground-up satellite clinic 9 miles east in a growing submarket for $280K capex plus working capital. Combined, the expansion would grow revenue capacity by roughly 2.5x within 18 months.

Challenge

Total expansion capital required was approximately $1.05M — $640K for the acquisition, $280K for the ground-up buildout, plus $130K in working-capital reserves to cover the 90-day insurance-claim payment cycle on the new locations during ramp. The owner's $310K of cash could cover roughly 30% of the need; the gap was $740K.

The first three pitches were predatory. A broker who learned about the expansion through an industry conference pitched a $400K MCA at a 1.39 factor on a 9-month term — that is approximately a 71% APR-equivalent on a deal the practice would have needed to roll for at least 24 months to align with the expansion ramp, compounding total cost above $300K in factor fees alone.

A second broker pitched a 'medical-specific' MCA at a 1.32 factor on a 12-month term — slightly better pricing but with a structure that swept 14% of daily insurance deposits, which would have crashed cash flow on the new clinics during their ramp. A third pitch from a 'revenue-based' shop quoted a 1.18 cap with a 12% revenue share — better than the MCAs, but still annualizing to roughly 24% APR and eating roughly $200K of total cost over the loan life.

All three pitches assumed the owner was either uninformed about pricing or in a hurry. The owner was neither.

Decision process

We worked the SBA 7(a) path. The deal structurally fit: profitable target acquisition with seller financing potentially on the table, owner with strong personal financials and clinical experience, no prior business debt, healthcare-services industry with strong SBA lender appetite, and total project size within the $5M SBA 7(a) ceiling.

We matched the owner to a preferred SBA lender with specific outpatient-healthcare acquisition experience. The structure that came together: a single $920K SBA 7(a) facility — $640K for the acquisition, $280K for the new-clinic buildout, $0 working capital (the owner's existing $310K of cash, less acquisition closing costs, covered the working capital need with margin). 10-year fully amortizing term at Prime + 2.25 (effective 10.75% APR at closing). 90% SBA guarantee. 10% equity injection from the owner ($102K, drawn from existing cash). Standard 2-year prepayment penalty schedule (5% year 1, 3% year 2, 0% thereafter).

Seller financing on the acquisition was added as a $96K seller note at 6% over 5 years, subordinated to the SBA facility — a structure the seller welcomed because it preserved long-term tax treatment on a portion of the sale.

Underwriting timeline: 78 days from engagement letter to funding. SBA submission to approval was 41 days. Bank closing took 37 days, slowed primarily by HIPAA-compliant lease assignment negotiations on the acquired clinic's facility lease (a real-world detail that the MCA pitches conveniently glossed over because they would never have surfaced it).

The total cost-of-capital math: $920K SBA 7(a) at 10.75% APR over 10 years produces total interest expense of approximately $574K over the loan life. The MCA stack alternative would have produced approximately $720K in factor cost over 24 months — to fund a smaller, more constrained deal. The RBF alternative would have produced approximately $200K of cost over 4–5 years on a partial-coverage facility that would still have required a second financing round.

Outcome

Acquisition closed in July 2025; ground-up clinic opened in January 2026. By month 7 of post-acquisition operations, the acquired clinic was EBITDA-positive on a stand-alone basis (it had been EBITDA-negative under prior ownership, primarily due to weak referral conversion and excessive admin overhead). By month 9, the new ground-up clinic crossed EBITDA breakeven, slightly ahead of the underwriting model.

On a Q1 2026 trailing run-rate basis, combined three-clinic revenue is $4.6M with a blended 19.4% pre-tax net margin — modestly below the pre-expansion 22% because of acquisition integration costs and ramp on the new clinic, with the model showing recovery to 21–22% by mid-2027. Monthly SBA debt service of approximately $12,650 represents 3.3% of monthly revenue at the current run-rate — a comfortable coverage ratio of 2.1x against earnings.

The owner reports the most valuable structural benefit was not the interest-rate savings but the working-capital headroom: every alternative would have required a second financing round during ramp. The single SBA 7(a) covered the entire expansion arc, leaving the owner's mental bandwidth focused on operations rather than on the next financing.

Lessons learned

• SBA 7(a) underwriting takes 60–90 days, but on multi-six-figure expansion capital, the rate differential against MCA or RBF is typically a 50%+ swing in total interest cost.
• Healthcare practices with clean financials, strong personal credit, and a profitable target acquisition are textbook SBA 7(a) candidates — work the SBA path first.
• Seller financing subordinated to an SBA note is a common acquisition structure; sellers often prefer it for capital-gains spreading.
• Brokers pitching MCAs on a healthcare expansion are almost always wrong-product. The deal mechanics (insurance-claim float, ramp curves, multi-location working capital) are hostile to daily-ACH structures.
• Single facility beats stacked financing on integration bandwidth — the second-order cost of managing multiple lenders during ramp is real.

Related reading

• SBA loan product overview
• Healthcare practice financing after Medicaid cuts
• Best MCA funders for medical practices 2026
• Find your funder match